Workflow
澳洋健康(002172) - 2014 Q2 - 季度财报
AYJKAYJK(SZ:002172)2014-08-25 16:00

Financial Performance - The company reported a revenue of ¥1,468,556,806.45, a decrease of 9.67% compared to the same period last year[18]. - The net profit attributable to shareholders was a loss of ¥45,531,128.64, representing a decline of 277.20% year-on-year[18]. - The net cash flow from operating activities was ¥141,317,047.51, down 42.80% from the previous year[18]. - The company's operating revenue for the reporting period was ¥1,468,556,806.45, a decrease of 9.67% compared to the same period last year[25]. - Operating costs amounted to ¥1,364,027,441.56, reflecting a reduction of 4.42% year-on-year[25]. - The company anticipates a net loss of between ¥60 million and ¥40 million for the first nine months of 2014, compared to a profit of ¥25.69 million in the same period last year[34]. - The company reported a gross margin of 6.79% in the chemical fiber industry, down from the previous year[28]. - The company reported a net loss of ¥58,451,829.79 compared to a net profit of ¥26,831,764.31 in the previous period, indicating a significant downturn[92]. - The basic and diluted earnings per share were both -¥0.08, down from ¥0.05 in the prior period[92]. Assets and Liabilities - The total assets at the end of the reporting period were ¥2,938,669,728.93, an increase of 2.89% compared to the end of the previous year[18]. - The total liabilities increased to CNY 2,170,442,690.33 from CNY 2,021,236,636.00, indicating a rise in financial obligations[86]. - The company's equity attributable to shareholders decreased to CNY 583,879,916.25 from CNY 637,616,164.89, reflecting a decline in retained earnings[86]. - The total current liabilities rose to CNY 2,129,610,287.23 from CNY 1,976,921,712.49, indicating increased short-term financial pressures[86]. - The total accounts receivable at the end of the period amounted to ¥75,369,114, with a bad debt provision of ¥5,396,437.8, representing 7.16% of the total[200]. Cash Flow - The net cash flow from investing activities improved by 76.01%, with a net outflow of ¥6,088,494.79 compared to a larger outflow in the previous year[25]. - The net cash flow from financing activities decreased by 46.12%, resulting in a net outflow of ¥103,028,452.87[25]. - Cash flow from operating activities generated a net cash inflow of ¥141,317,047.51, a decrease from ¥247,078,833.97 in the previous period[98]. - The total cash outflow for financing activities was 1,013,161,452.87, indicating a high level of financial obligations[99]. - The company’s cash inflow from operating activities was significantly lower than the previous period, indicating potential challenges in revenue generation[100]. Business Operations - The company’s main business, viscose staple fiber, accounted for 99.18% of total revenue[24]. - The viscose staple fiber market experienced a slight price decline, with prices stabilizing and slightly recovering in the second quarter[23]. - The company is focusing on cost reduction and efficiency improvement to enhance its competitive advantage in a challenging market environment[23]. - The company plans to optimize inventory management and adjust production strategies based on market trends[23]. - The company operates in the viscose staple fiber industry, focusing on the production and sales of viscose fibers, biodegradable fibers, and functional fibers[122]. Shareholder Information - The company will not distribute cash dividends or issue bonus shares for this period[4]. - The total number of ordinary shareholders at the end of the reporting period was 38,818[75]. - The largest shareholder, Aoyang Group Co., Ltd., holds 42.67% of the shares, with a total of 240,082,979 shares[75]. - The company has committed to ensuring that no more than 25% of its total shares will be transferred during the tenure of its major shareholder[65]. - The company has maintained compliance with its commitments regarding share transfers and has not faced any penalties or rectifications during the reporting period[68][69]. Research and Development - The company has established a research and development center for differentiated viscose products, which has led to the development of multiple patented technologies[29]. - The company plans to continue its market expansion efforts, focusing on enhancing its product offerings and technological advancements[113]. - The company has outlined strategies for potential mergers and acquisitions to further strengthen its market presence and operational capabilities[186]. Compliance and Governance - No significant changes in profit structure or major litigation issues were reported during the period[26][40]. - The company did not engage in any major transactions or events that require additional explanation during the reporting period[69]. - The financial report for the half-year period has not been audited[68]. - The company did not undergo any changes in its board of directors or senior management during the reporting period[81]. Accounting Policies - The financial statements are prepared based on the assumption of going concern and comply with the accounting standards issued by the Ministry of Finance[123][124]. - The company recognizes financial assets transferred to other parties based on the transfer of risks and rewards associated with those assets[137]. - The company conducts impairment testing on financial assets, recognizing impairment losses when the present value of expected future cash flows is less than the carrying amount[140]. - The company assesses deferred tax assets based on the likelihood of future taxable income to utilize temporary differences[178].